文献
J-GLOBAL ID:202202216700263070
整理番号:22A0475784
ALK再配列非小細胞肺癌(NSCLC)患者の遺伝的景観とASCEND-1研究におけるセリチニブに対する反応【JST・京大機械翻訳】
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study
著者 (15件):
Tan D.S-W.
(Division of Medical Oncology, National Cancer Centre Singapore, Singapore)
,
Thomas M.
(Onkologie der Thoraxtumoren, Thoraxklinik im Universitaetsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany)
,
Kim D-W.
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Szpakowski S.
(Novartis Institutes for Biomedical Research, Cambridge, MA)
,
Urban P.
(Novartis Pharma AG, Basel, Switzerland)
,
Mehra R.
(Fox Chase Cancer Center, Philadelphia, PA)
,
Chow L.Q.M.
(University of Washington, Seattle, WA)
,
Sharma S.
(Huntsman Cancer Institute, Salt Lake City, UT)
,
Solomon B.J.
(Peter MacCallum Cancer Centre, Melbourne, VIC, Australia)
,
Felip E.
(Vall d’Hebron University, Barcelona, Spain)
,
Camidge D.R.
(University of Colorado, Aurora, CO)
,
Vansteenkiste J.
(University Hospital KU Leuven, Leuven, Belgium)
,
Petruzzelli L.
(Novartis Institutes for Biomedical Research, Cambridge, MA)
,
Pantano S.
(Novartis Pharma AG, Basel, Switzerland)
,
Shaw A.T.
(Massachusetts General Hospital, Boston MA)
資料名:
Lung Cancer
(Lung Cancer)
巻:
163
ページ:
7-13
発行年:
2022年
JST資料番号:
W3184A
ISSN:
0169-5002
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)